Shares of Puma Biotechnology PBYI have witnessed a sharp increase in the past three months, driven by investor optimism ...

As AI transforms biology, longevity startups are attracting investors, advancing toward clinical milestones, and reshaping ...

Danaher is seeing strong Biotechnology growth as bioprocessing demand rises, with equipment orders up more than 30% and core ...

Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the appointment of Timothy Coughlin to its Board of Directors and as Chair of the Audit Committee, effective June 9, 2026.

China's Biotechnology Push Representational Image Washington, June 12: China is aggressively pursuing dominance in the ...

The US should be doing all it can to preserve its lead in pharmaceutical innovation against a resurgent China. Instead, it’s punishing a company whose main business is helping American firms discover, ...

Biotech stocks are considered extremely high-risk, high-reward investments. Many biotech companies are developing one or more ...

Vir Biotechnology develops antibody and RNA-based therapies for infectious diseases, leveraging partnerships and a robust clinical pipeline.

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...

WPI offers more than 70 degree and certificate programs to meet a range of academic interests. More than three dozen academic ...